BIO Applauds Creation Of FDA Opioid Policy Steering Committee

WASHINGTON--(BUSINESS WIRE)--Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the announced creation of an Opioid Policy Steering Committee at the Food and Drug Administration (FDA):

“We commend Commissioner Gottlieb for his leadership in establishing the Opioid Policy Steering Committee. His swift action in this area demonstrates that addressing the growing opioid crisis will be a top priority for the Agency under his leadership.

“America’s biopharmaceutical companies are committed to finding solutions to help curb opioid abuse. Several of our member companies are developing non-addictive, next generation therapies with the potential to transform the standard of care for pain management. They are also working to develop new opioid formulations that prevent or deter improper use, such as tamper-proof pills, and taking steps to increase their prescriber education efforts.

“We stand ready to work with Commissioner Gottlieb and the Committee to better meet the needs of patients with chronic and acute pain.”

About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.

Upcoming BIO Events

BIO International Convention

June 19-22, 2017

San Diego, CA

BIO World Congress on Industrial Biotechnology

July 23-26, 2017

Montreal, Canada

Biotechnology Innovation Organization (BIO)
Daniel Seaton, 202-470-5207
Web: www.bio.org
Blog: www.biotech-now.org
Twitter: @IAmBiotech

Back to news